期刊
CIRCULATION
卷 136, 期 14, 页码 1331-1345出版社
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1161/CIRCULATIONAHA.116.022572
关键词
coronary artery bypass; grafts; mammary arteries; myocardial revascularization; radial artery
资金
- Medistim, Inc, Oslo, Norway
- Medistim, Inc.
- Vascular Graft Solutions, Tel Aviv, Israel
- Vascular Graft Solutions
- British National Institutes of Health
- British Heart Foundation
- US National Heart, Lung, and Blood Institute [UO1 HL125488-01A1]
- Scanlan Inc.
Coronary artery bypass grafting remains one of the most commonly performed major surgeries, with well-established symptomatic and prognostic benefits in patients with multivessel and left main coronary artery disease. This review summarizes current indications, contemporary practice, and outcomes of coronary artery bypass grafting. Despite an increasingly higher-risk profile of patients, outcomes have significantly improved over time, with significant reductions in operative mortality and perioperative complications. Five-and 10-year survival rates are approximate to 85% to 95% and 75%, respectively. A number of technical advances could further improve short- and long-term outcomes after coronary artery bypass grafting. Developments in off-pump and no-touch procedures; epiaortic scanning; conduit selection, including bilateral internal mammary artery and radial artery use; intraoperative graft assessment; minimally invasive procedures, including robotic-assisted surgery; and hybrid coronary revascularization are discussed.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据